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a b s t r a c t
Ooplasmic factors drive nuclear organization after fertilization
and are also important for re-programming in nuclear transfer
procedures, in which artiﬁcial activation is essential for recon-
structed embryos to progress in development. The present research
evaluated the effect of pronuclear transfer (PT) between zygotes
parthenogenetically activated with ionomycin followed by stron-
tium (S) or 6-DMAP (D) on early embryonic development. PT was
performed in the same zygote to obtain embryos in control groups
(S-PT and D-PT) and between zygotes activated with S and D to
achieve embryos with differentially activated cytoplasm (C) and
nucleus (N) (SCDN and DCSN). PT procedure did not affect cleavage
and blastocyst rates, respectively, in PT control groups compared
to non-manipulated control (S-PT: 73.6% and 7.3% compared with
S-Control: 77.9% and 7.8%; and D-PT: 73.3% and 31.7% compared
with D-Control: 83.1% and 41.5%). Cleavage, eight-cell, and blasto-
cyst rates, respectively, were similar between SCDN (76.5%, 36.4%,
and 6.8%) and DCSN (69.5%, 25.0%, and 4.9%) embryos. Develop-
mental rates in SCDN were similar to S-PT, but inferior to D-PT.
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Developmental arrest up to eight-cell stage was greater in SCDN
andDCSN than in S-PT andD-PT. In conclusion, karyoplast exchange
between parthenogenetic zygotes activated with strontium and 6-
DMAP can lead to nuclear–cytoplasmic incompatibilities and affect
embryonic development to the eight-cell and blastocyst stages.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
After fertilization, ooplasmic factors drive mutual modiﬁcations between maternal and pater-
nal genomes, which are essential for embryonic development (Moore and Reik, 1996; Mann and
Bartolomei, 2002). The ooplasm ability to re-program the genome also has an important role in
the success of somatic cell nuclear transfer (SCNT). Following SCNT, the re-constructed embryo
requires an activation stimulus to progress in development. Among several agents used for acti-
vation, ionomycin and strontium (Cuthbertson et al., 1981) promote intracellular calcium increase,
whereas 6-dimethylaminopurine (6-DMAP; Susko-Parrish et al., 1994) inhibits protein phosphoryla-
tion.
Because different activation treatments function through distinct pathways, resulting modiﬁca-
tions of the oocyte nucleus and cytoplasm are also variable. From previous observations (Méo et al.,
2007), 6-DMAP affects spindle organization and accelerates cell cycle progression when compared
to strontium, which is considered a more physiological treatment that promotes periodical intracel-
lular calcium pulses similar to fertilization in mice (Bos-Mikich et al., 1995). Greater developmental
rates are achieved when 6-DMAP is used for activation. Thus, there is great interest in searching for
more physiological treatments that promote greater rates of activation, especially in cattle given the
increased interest in cloning and transgenesis in this species for research and commercial purposes
(Niemann and Kues, 2007).
In the present study, zygotes activated with ionomycin followed by strontium or 6-DMAP were
submitted to pronuclear transfer (PT). Because interaction between nucleus and cytoplasm begins
immediately subsequent to fertilization or activation, PT between zygotes would allow the evalu-
ation of resulting modiﬁcations. To our knowledge, this is the ﬁrst report on karyoplast exchange
between activated zygotes of cattle and objectives were to evaluate its effects on early embryonic
development and to assesswhether 6-DMAP activated cytoplasm and karyoplastwere able to improve
developmental rates achieved in strontium-activated zygotes.
2. Materials and methods
2.1. Chemicals and media
Chemicals and media were purchased from Sigma–Aldrich (St. Louis, MO, USA), unless otherwise
stated. Culture conditions during all experiments were in droplets (100L) under mineral oil (Dow
Corning Co., Midland, MI, USA) with 20–25 oocytes or embryos per drop at 38.5 ◦C under 5% CO2 in air
andmaximumhumidity. Allmediawere supplementedwith 0.2mMsodiumpyruvate and 83.4g/mL
amikacin (Instituto Biochimico, Rio de Janeiro, RJ, Brazil).
2.2. Oocyte recovery and in vitro maturation
Follicles (3–7mm) were aspirated from abattoir-derived bovine ovaries, and oocytes with at least
four layers of cumulus cells and homogeneous ooplasm were selected for in vitro maturation (IVM).
IVMwasperformed for24h in tissue culturemedium(TCM-199;GibcoBRL,Grand Island,NY,USA) sup-
plemented with 10% fetal calf serum (FCS; Cripion, Andradina, SP, Brazil), 1.0g/mL FSH (FolltropinTM,
Bioniche Animal Health, Belleville, Ont., Canada), 50g/mL hCG (ProfasiTM, Serono, São Paulo, SP,
Brazil), and 1.0g/mL estradiol.
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2.3. Artiﬁcial activation
After IVM, oocytes were stripped from cumulus cells by gentle pipetting in 0.5% hyaluronidase
(HyalozimaTM, Aspen, São Paulo, SP, Brazil). Denuded oocytes with an extruded ﬁrst polar body were
activated with 5M ionomycin for 5min in Hepes-buffered synthetic oviductal ﬂuid (HSOF). After
that, oocyteswere treatedwith 20mMstrontium (SrCl2; J.T. Baker, Phillipsburg, NJ, USA) and 10g/mL
cytochalasin D (Cyto D) for 6h in Ca2+- and Mg2+-free TALP (S); or with 2mM 6-dimethylaminopurine
(6-DMAP) for 4h in TALP (D). After activation, oocytes were kept in TALP until further utilization.
2.4. Centrifugation
Presumptive zygotes after 16–24h of activation were centrifuged in HSOF with Cyto D at 15,000× g
for 15min at 25 ◦C for lipid droplet separation. Pronuclei were visualized using an invertedmicroscope
Olympus IX-70 equipped with Hoffman Modulator Contrast. Activated zygotes submitted to culture
after centrifugation and pronuclear evaluation constituted the non-manipulated control groups: S-
Control (n=77) and D-Control (n=65).
2.5. Pronuclear transfer
Pronuclear transfer (McGrath and Solter, 1984; Westhusin and De Azambuja, 1996) was performed
inHSOFwith 7.5g/mL cytochalasin B. Four experimental groupswere produced: two in the PT control
group, where removed karyoplast (pronucleus and adjacent cytoplasm) of one zygote was transferred
back to the perivitelline space of the same zygote in S (S-PT; n=216) or D (D-PT; n=165) treatments;
and two in the PT differentially activated group, where the karyoplast was removed from a zygote of
one activation treatment and was then transferred to a previously enucleated zygote from the other
treatment, which allowed the production of embryos with S cytoplasm and D nucleus (SCDN; n=255)
and D cytoplasm and S nucleus (DCSN; n=279).
Cytoplasm–karyoplast complexeswere fused ina0.28Mmannitol solutioncontaining0.1mMCaCl2
(Merck, Darmstadt, Germany), 0.1mMMgSO4 (Merck), and 3mg/mL bovine serum albumin (BSA). Cell
fusion was induced by two direct pulses of 1.5 kV/cm for 30s each.
2.6. Culture and assessment of early embryonic development
Embryos were co-cultured with granulosa cells in SOF supplemented with 2.5% FCS and 3mg/mL
BSA for 7 days. Cleavage at 46–48h after activation, eight-cell stage on Day 4, and blastocyst develop-
ment rates on Day 7 were assessed under a stereoscopic microscope (at 50× magniﬁcation).
2.7. Statistical analysis
Experiments were replicated at least three times. Embryonic development rates were analyzed
by Chi-square test and, when appropriate, by Fisher’s exact probability test using SAS. A level of 5%
signiﬁcance was used.
3. Results
Differences (p<0.05) in pronuclear development rates were observed between activation treat-
ments: 39.1% for S and 43.2% for D. Pronuclear transfer had no effect on cleavage and blastocyst
developmental rates, respectively, since the results obtained in S-PT (73.6% and 7.3%) and D-PT (73.3%
and 31.7%) were, respectively, similar (p>0.05) to that obtained in non-manipulated control zygotes:
S-Control (77.9% and 7.8%) and D-Control (83.1% and 41.5%).
Karyoplast exchange betweendifferentially activated zygotes resulted in embryoswith S cytoplasm
andDnucleus andD cytoplasm and S nucleus, whichwere compared to control groups (S-PT andD-PT;
Fig. 1). All groups presented similar (p>0.05) cleavage rates (Fig. 1). For eight-cell development rates,
S-PT was similar (p>0.05) to D-PT and SCDN, but SCDN was inferior (p<0.05) to D-PT, while DCSN
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Fig. 1. Cleavage (46–48h) and development of cattle embryos to eight-cell (Day 4) and blastocyst (Day 7) stages in pronuclear
transfer control (S-PT and D-PT) and differentially activated (SCDN and DCSN) embryos. S: oocytes activated with iono-
mycin + strontium, D: oocytes activatedwith ionomycin +6-DMAP, C: cytoplasm, N: nucleus. abcdBarswith different superscripts
are different (p<0.05).
was inferior (p<0.05) to S-PT and D-PT, but similar (p>0.05) to SCDN (Fig. 1). Regarding blastocyst
development, D-PT was superior (p<0.05) to S-PT, SCDN, and DCSN (Fig. 1).
In S-PT andD-PTgroups, development rates to the eight-cell stagewere similar (p>0.05) to cleavage
rates, however, there was a decrease (p<0.05) in blastocyst development rates (Fig. 1). In SCDN and
DCSN, there was a decrease (p<0.05) in developmental rates from the two-cell to the eight-cell stage
and then also to the blastocyst stage (Fig. 1).
4. Discussion
Strontium and 6-DMAP activation treatments act by distinct pathways. While the ﬁrst promotes
periodical intracellular calcium pulses similar to fertilization in mice (Bos-Mikich et al., 1995), the
second inhibits protein phosphorylation. Although activation with strontium would be more physio-
logical, 6-DMAP promotes higher developmental rates (Méo et al., 2007). As expected, in the present
study greater pronuclear formation rates were obtained in D compared to S treatment. However,
because only zygoteswith a visible pronucleuswere used for pronuclear transfer procedures, effects of
different pronuclear rates between treatments on further embryonic development were minimized.
PT control embryos were produced after removal and transfer of the same karyoplast to the same
zygote in each activation treatment (S-PT and D-PT). PT had no detrimental effect on cleavage and
blastocyst development rates. This is in agreement with results obtained after pronuclear transfer in
embryos of cattle produced by in vitro fertilization (Westhusin and De Azambuja, 1996).
After that, PT was performed between strontium and 6-DMAP activated zygotes to obtain SCDN
and DCSN embryos. It was expected that embryos re-constructed with the 6-DMAP nucleus (SCDN)
would have a similar response to D-PT and improve developmental rates achieved in S-PT, but the
opposite was observed: blastocyst development rate in SCDN was similar to S-PT and inferior to D-PT.
Because DCSN was also similar to S-PT and inferior to D-PT, it suggests that both the cytoplasm and
karyoplast from strontium-activated zygotes negatively affected 6-DMAP-activated zygotes. Also, 6-
DMAP-activatedkaryoplast andcytoplasmwerenot able to improvedevelopmental ratesof S-activated
zygotes.
The reason for that interaction between nucleus and cytoplasm of these two activation treatments
is not clear. One hypothesis is that cell cycle incompatibilities between these activation treatments
may occur because 6-DMAP accelerates pronuclear development and cell cycle progression when
compared to strontium (Méo et al., 2007). However, because only zygotes in pronuclear stage were
used, in this case the cell cycle would not be an important factor to interfere on further embryonic
development.
Based on results from the present study, the detrimental effect of strontium is assumed to be
mediated through its cytoplasm (the recipient cytoplasmor the cytoplasmsurrounding the transferred
pronucleus) and that it was established early in a period between activation and pronuclear formation,
because it could not be recovered by karyoplast exchange with 6-DMAP-activated zygotes. This effect
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of strontium may be similar to that observed in mouse DDK syndrome (Renard and Babinet, 1986),
but the reduced developmental potential was observed as soon as at the eight cell stage. Interestingly,
while strontium promotes similar or lesser developmental rates to blastocyst when compared to 6-
DMAP for parthenogenetic activation (Yamazaki et al., 2005;Méo et al., 2007), it results in greater rates
when used in SCNT procedures (Yamazaki et al., 2005), in which the activation of recipient oocytes is
performed after enucleation and transfer of donor nucleus. Therefore, further studies are necessary
to investigate the components present on zygotes after each activation treatment that may affect the
development of the resulting embryos.
5. Conclusion
Karyoplast exchange between zygotes of cattle activated with strontium and 6-DMAP can generate
nucleus–cytoplasmic incompatibility that does not affect cleavage rates, but disturbs development to
eight-cell and blastocyst stages.
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